Saitama, Japan

Hideaki Nagai

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideaki Nagai. Retrieved from https://idiyas.com/inventor/hideaki-nagai-14ncvwqq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideaki Nagai

Introduction

Hideaki Nagai is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in reducing blood glucose levels. His work is essential in the ongoing fight against diabetes and related health issues.

Latest Patents

Nagai holds a patent for "3-Substituted-ureido-N-pyridyl benzamides." This patent describes benzamide derivatives that include various substituents, which are designed to have medicinal properties. The compounds are characterized by their ability to lower blood glucose levels, making them valuable in pharmaceutical applications.

Career Highlights

Nagai is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on innovative drug development, contributing to advancements in medical treatments.

Collaborations

Nagai has collaborated with notable colleagues such as Noriko Kawamura and Takashi Dan. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Hideaki Nagai's contributions to pharmaceutical innovations are noteworthy, particularly in the area of diabetes treatment. His patent and work at Chugai Seiyaku Kabushiki Kaisha highlight his commitment to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…